Details of the Drug Reposition

General Information of This Drug (ID: DMYYEM5)

• Drug Name: CMB305 (DMYYEM5)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 2	[1]
Soft tissue sarcoma	DISSN8XB	2B57	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)